Stay updated on Palbociclib After CDK and Endocrine Therapy Clinical Trial

Sign up to get notified when there's something new on the Palbociclib After CDK and Endocrine Therapy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Palbociclib After CDK and Endocrine Therapy Clinical Trial page

  1. Check
    13 days ago
    No Change Detected
  2. Check
    20 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.0%
    Check dated 2025-05-01T05:51:41.000Z thumbnail image
  3. Check
    28 days ago
    No Change Detected
  4. Check
    35 days ago
    Change Detected
    Summary
    The page has undergone significant content changes, including the removal of detailed descriptions of a Phase II clinical trial for metastatic breast cancer and the addition of new collaborators and a revision number. Notably, the name of the principal investigator has been updated.
    Difference
    53%
    Check dated 2025-04-16T15:18:18.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to March 6, 2025.
    Difference
    0.1%
    Check dated 2025-04-09T10:55:11.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new last update date of March 25, 2025, and a revision change to version 2.14.3, replacing the previous date of March 6, 2025, and version 2.14.2.
    Difference
    0.1%
    Check dated 2025-04-01T23:47:50.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    The webpage has updated its date references, removing several past dates from 2024 and adding new dates in 2025.
    Difference
    0.7%
    Check dated 2025-03-11T05:58:17.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    0.8%
    Check dated 2025-02-24T22:46:19.000Z thumbnail image

Stay in the know with updates to Palbociclib After CDK and Endocrine Therapy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Palbociclib After CDK and Endocrine Therapy Clinical Trial page.